N. Vianelli et al., INTERFERON-ALPHA-2B IS NOT EFFECTIVE IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA, Haematologica, 83(8), 1998, pp. 761-763
About 25-30% of patients with immune thrombocytopenic purpura (ITP) ar
e refractory to corticosteroids, splenectomy and other treatments. It
has been suggested that interferon-alpha 2b (IFN-alpha 2b) may be usef
ul in the treatment of chronic refractory ITP patients. We treated 9 c
hronic refractory ITP patients with IFN-alpha 2b: the results were poo
r.